Table 1.
Four-channel | Placebo | Dual-channel | |
---|---|---|---|
(n = 16) | (n = 15) | (n = 14) | |
Age (years) | 63.4 ± 10.6 | 67.0 ± 9.0 | 64.6 ± 8.3 |
Gender (male/female) | 8/8 | 8/9 | 8/6 |
Brunnstrom (I/II/IV) | 1/4/11 | 1/6/8 | 1/4/9 |
Time since onset (days) | 41.3 ± 29.4 | 41.5 ± 20.4 | 41.6 ± 22.1 |
Four-channel, placebo, and dual-channel denote groups which received four-channel FES, four-channel FES placebo, and dual-channel FES, respectively. Value: mean ± SD.